newsfilter
← Latest News
GlobeNewswire·

Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes

CORAL GABLES, Fla., June 29, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (NASDAQ:RLMD, "Relmada" or the "Company")), a clinical-stage biotechnology company advancing innovative therapies for